Plasminogen/plasminogen activator and growth factor activation

CIBA Foundation Symposia

Volumn , Issue 212, 1997, Pages 105-118

  Rifkin, D B ^a   Gleizes, P E ^a   Harpel, J ^a   Nunes, I ^a   Munger, J ^a   Mazzieri, R ^a   Noguera, I ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; BIOSYNTHESIS; CANCER INVASION; HUMAN; HYDROLYSIS; METABOLISM; REVIEW; STIMULATION;

ANIMALS; GROWTH SUBSTANCES; HUMANS; HYDROLYSIS; NEOPLASM INVASIVENESS; PLASMINOGEN; PLASMINOGEN ACTIVATORS; PROTEINS; STIMULATION, CHEMICAL; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031298718     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Antonelli-Olridge A, Saunders KB, Smith SR, D'Amore PA 1989 An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544-4548
2. Barcellos-Hoff MH, Derynck R, Tsang M L-S, Weatherbee JA 1994 Transforming growth factor-β activation in irradiated murine mammary glands. J Clin Invest 93:892-899
3. Brown P, Wakefield L, Levinson A, Sporn, M 1990 Physiochemical activation of recombinant latent transforming growth factor-betas 1, 2, 3. Growth Factors 3:35-43
4. Bugge TH, Flick MJ, Daugherty CC, Degen JL 1985 Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9:794-807
5. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJS, Degen JL 1996 Loss of fibrinogen rescues mice from pleiotropic effects of plasminogen deficiency. Cell 87:709-720
6. Dano K, Andreasen PA, Grondahl-Hanson J, Kristensen P, Nielsen LS, Skriver L 1995 Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139-266
7. Dennis PA, Rifkin DB 1991 Cellular activation of latent transforming growth factor-β requires binding to the cation-independent mannose 6 phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88: 580-584
8. Flaumenhaft R, Rifkin DB 1992 The regulation of growth factor action. Mol Biol Cell 3:1057-1065
9. Flaumenhaft R, Abe M, Sato Y et al 1993 Role of the latent TGF-β binding protein in the activation of latent TGF-β by cocultures of endothelial cells and smooth muscle cells. J Cell Biol 120:995-102
10. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalf JC 1994 Activation of transforming growth factor-β is linked in transgenic apolipoprotein (a) mice. Nature 370:460-462
11. Grainger DJ, Kemp PR, Metcalfe JC et al 1995 The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med 1:74-79
12. Holmgren L, O'Reilly MS, Folkman J 1995 Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153
13. Kojima S, Rifkin DB 1993 Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Physiol 155:323-332
14. Kojima S, Harpel PC, Rifkin DB 1991 Lipoprotein (a) inhibits the generation of transforming growth factor β: an endogenous inhibitor of smooth muscle cell migration. J Cell Biol 113:1439-1445
15. Kojima S, Nara K, Rifkin DB 1993 A requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol 121:439-448
16. Lyons RM, Keski-Oja J, Moses HL 1988 Proteolytic activation of latent transforming growth factor-β from fibroblast conditioned medium. J Cell Biol 106:1659-1665
17. Lyons RM, Gentry LE, Purchio AF, Moses HL 1990 Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin. J Cell Biol 110:1361-1367
18. Massague J 1990 The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641
19. Matsumoto T, Gargosky SE, Iwasaki K, Rosenfeld RG 1996 Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 81:150-155
20. Mignatti P, Rifkin DB 1993 Biology and biochemistry of proteinases in tumor invasion. Phys Rev 73:161
21. Miyazono K, Hellman U, Wernstelt C, Heldin C-H 1991 Latent high molecular weight complex of transforming growth factor-β1 binding protein in the assembly and secretion of TGF-β 1. EMBO J 10:1091-1101
22. Naldini L, Tamagnone G, Vigna E et al 1992 Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor. EMBO J 11:4825-4833
23. Nunes I, Shapiro R, Rifkin DB 1995 Characterization of latent TGF-β activation by murine peritoneal macrophages. J Immunol 1450-1459
24. Nunes I, Munger JE, Harpel JG et al 1996a Structure and activation of the large latent transforming growth factor-β complex. Int J Obes 20 (suppl 3): S4-S8
25. Nunes I, Kojima S, Rifkin DB 1996b Effects of endogenously activated transforming growth factor-β on growth and differentiation of retinoic acid-treated HL-60 cells. Cancer Res 56:495-499
26. Nunes I, Gleizes P-E, Metz CN, Rifkin DB 1997 Latent TGF-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent TGF-β. J Cell Biol 136:1151-1163
27. Odekon L, Blasi F, Rifkin DB 1994 A requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J Cell Physiol 158:398-407
28. O'Reilly MS, Holmgren L, Shing Y et al 1994 Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis Lung carcinoma. Cell 79:315-328
29. Ossowski L, Quigley JP, Reich E 1975 Plasminogen, a necessary factor for cell migration in vitro. In: Reich E, Rifkin DB, Shaw E (eds) Proteases and biological control. Cold Spring Harbor Press, Cold Spring Harbor, NY, p 901-914
30. Roberts AB, Sporn MB 1990 The transforming growth factor-βs. Springer-Verlag, New York Inc., New York
31. Saksela O, Rifkin DB 1988 Cell associated plasminogen activation: regulation and physiological function. Annu Rev Cell Biol 4:93-145
32. Sato Y, Rifkin DB 1989 Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming β1 like molecule by plasmin during co-culture. J Cell Biol 109:309-315
33. Sato Y, Tsuboi R, Lyons RM, Moses H, Rifkin DB 1990 Characterization of the activation of latent TGF-β by cocultures of endothelial cells and pericytes on smooth muscle cells: a self-regulating system. J Cell Biol 111:757-783
34. Schultz-Chèrry S, Ribeiro S, Gentry L, Murphy-Ulrich JE 1995 Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 269:26775-26782
35. Shimora T, Miyazawa K, Komiyama Y et al 1995 Activation of hepatocyte growth factor by two homologous proteases, blood coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 229: 257-261
36. Taipale J, Miyazono K, Heldin C-H, Keski-Oja J 1994 Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 124:171-181